Question to the Department of Health and Social Care:
To ask His Majesty's Government what is the number and percentage of lots across NHS Supply Chain's currently active medical device frameworks which have a hurdle rate, defined as the minimum overall evaluation score required for framework appointment, equal to or less than the maximum financial score achievable; and whether they intend to publish a breakdown by framework.
The NHS Supply Chain undertakes procurements under the Procurement Act 2023. This procurement typically leads to a set of agreements, or frameworks, with a range of suppliers for a category of products with pre-agreed terms for trade and the right to undertake further competition. All procurement has selection criteria that must be achieved to be successful in the tender process, and this is outlined to suppliers who are participating. It is usual for the minimum criteria to be placed on specific pre-qualification questions and the overall score.
For NHS Supply Chain tenders, the Cabinet Office standard selection questionnaire is used to ensure that any supplier is safe and legally able to supply goods to the National Health Service, and failure in any element will lead to removal from the tender process. At tender, the number of suppliers who are successful may also be limited, therefore only the highest scoring across the selection criteria will be awarded agreements. This is to ensure that suppliers who do not achieve high performance across both technical and commercial elements do not receive a framework award.
The selection criteria are set on a case-by-case basis and often at the lot level and not at the framework level, however, elements set out by Government policy, such as social value, are always weighted as required. The commercial submission, including price, is typically set at 40% and the minimum score also at approximately 40%.
Further competition is then conducted, but only when products achieve the required product quality and efficacy assurance from clinical specialists within NHS Supply Chain and/or external clinicians. No products are made available to buy without full product assurance.